202 related articles for article (PubMed ID: 16732552)
1. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain.
Dolcetta D; Perani L; Givogri MI; Galbiati F; Amadio S; Del Carro U; Finocchiaro G; Fanzani A; Marchesini S; Naldini L; Roncarolo MG; Bongarzone E
J Gene Med; 2006 Aug; 8(8):962-71. PubMed ID: 16732552
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction.
Luddi A; Volterrani M; Strazza M; Smorlesi A; Rafi MA; Datto J; Wenger DA; Costantino-Ceccarini E
Neurobiol Dis; 2001 Aug; 8(4):600-10. PubMed ID: 11493025
[TBL] [Abstract][Full Text] [Related]
3. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
[TBL] [Abstract][Full Text] [Related]
4. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
[TBL] [Abstract][Full Text] [Related]
5. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
[TBL] [Abstract][Full Text] [Related]
6. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease.
Galbiati F; Givogri MI; Cantuti L; Rosas AL; Cao H; van Breemen R; Bongarzone ER
J Neurosci Res; 2009 Jun; 87(8):1748-59. PubMed ID: 19185028
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy.
Lattanzi A; Salvagno C; Maderna C; Benedicenti F; Morena F; Kulik W; Naldini L; Montini E; Martino S; Gritti A
Hum Mol Genet; 2014 Jun; 23(12):3250-68. PubMed ID: 24463623
[TBL] [Abstract][Full Text] [Related]
8. Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.
Costantino-Ceccarini E; Luddi A; Volterrani M; Strazza M; Rafi MA; Wenger DA
Neurochem Res; 1999 Feb; 24(2):287-93. PubMed ID: 9972877
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
[TBL] [Abstract][Full Text] [Related]
10. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
[TBL] [Abstract][Full Text] [Related]
11. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.
Rafi MA; Fugaro J; Amini S; Luzi P; de Gala G; Victoria T; Dubell C; Shahinfar M; Wenger DA
Biochem Mol Med; 1996 Aug; 58(2):142-50. PubMed ID: 8812733
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation.
Pellegatta S; Tunici P; Poliani PL; Dolcetta D; Cajola L; Colombelli C; Ciusani E; Di Donato S; Finocchiaro G
Neurobiol Dis; 2006 Feb; 21(2):314-23. PubMed ID: 16199167
[TBL] [Abstract][Full Text] [Related]
14. Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.
Scruggs BA; Zhang X; Bowles AC; Gold PA; Semon JA; Fisher-Perkins JM; Zhang S; Bonvillain RW; Myers L; Li SC; Kalueff AV; Bunnell BA
Stem Cells; 2013 Aug; 31(8):1523-34. PubMed ID: 23606584
[TBL] [Abstract][Full Text] [Related]
15. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.
Meneghini V; Lattanzi A; Tiradani L; Bravo G; Morena F; Sanvito F; Calabria A; Bringas J; Fisher-Perkins JM; Dufour JP; Baker KC; Doglioni C; Montini E; Bunnell BA; Bankiewicz K; Martino S; Naldini L; Gritti A
EMBO Mol Med; 2016 May; 8(5):489-510. PubMed ID: 27025653
[TBL] [Abstract][Full Text] [Related]
16. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
Shen JS; Watabe K; Ohashi T; Eto Y
Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
[TBL] [Abstract][Full Text] [Related]
18. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
19. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.
Pan X; Sands SA; Yue Y; Zhang K; LeVine SM; Duan D
Hum Gene Ther; 2019 Sep; 30(9):1039-1051. PubMed ID: 31184217
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
